Medication info

Empagliflozin 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Linagliptin Micronized›5mg / 1 tabletEmpagliflozin Amorphous›25mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202502185 · Approved 2025.08.22

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from combination therapy with empagliflozin and linagliptin should receive their previous doses. This drug may be taken with or without food. Swallow the tablet whole. If a dose of this drug is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dosage adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or greater. No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Since this drug has not been studied in patients with severe hepatic impairment, its use is not recommended. No dosage adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication assists in blood sugar control when used along with dietary and exercise therapy for patients with type 2 diabetes who have difficulty controlling blood sugar levels. The two ingredients, empagliflozin and linagliptin, work together to effectively lower blood sugar levels. Therefore, this medication is used to improve blood sugar management in type 2 diabetes.

How to take

Adult dose

The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from combination therapy with empagliflozin and linagliptin should receive their previous doses. This drug may be taken with or without food. Swallow the tablet whole. If a dose of this drug is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dosage adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or greater. No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Since this drug has not been studied in patients with severe hepatic impairment, its use is not recommended. No dosage adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains two ingredients, empagliflozin and linagliptin, and is primarily used for the treatment of diabetes. First, this medication should not be used by patients with allergies to empagliflozin or linagliptin, or to other ingredients contained in the medication, nor should it be used by patients with type 1 diabetes, diabetic ketoacidosis, or those on dialysis. Caution should be exercised when using in patients with impaired kidney function, heart failure, a history of pancreatitis, or suspected bullous pemphigoid, a skin condition. The most common side effect associated with this medication during usage is urinary tract infection, while rare but serious side effects including ketoacidosis, pancreatitis, hypersensitivity reactions, and hypoglycemia may also occur. Particularly, there is a risk of hypoglycemia when this medication is taken with insulin or sulfonylureas; caution is warranted. Also, symptoms of low blood pressure or dehydration due to fluid loss may emerge, so those being treated for hypertension, elderly patients, and individuals with a history of low blood pressure should exercise additional caution when taking this medication. This medication may increase the risk of urinary tract infections and genital fungal infections, so if infection symptoms appear, immediate consultation with healthcare providers is recommended. Women who are pregnant or breastfeeding are advised not to use this medication unless specifically instructed; it is recommended to stop breastfeeding during treatment. Use in children under 18 years is not recommended due to the lack of established safety and efficacy.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infections
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 154 more
  • ketosis
  • cough
  • constipation
  • pancreatitis
  • oral ulceration
  • pruritus
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • abdominal pain
  • enterocolitis
  • bowel obstruction
  • gastroenteritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorders
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • vascular stent stenosis
  • vascular stent thrombosis
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • dizziness
  • kidney transplant failure
  • concussion
  • meniscal injury
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholecystitis
  • autoimmune hepatitis
  • hearing loss
  • erectile dysfunction
  • goiter
  • anxiety
  • mood disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • palpitations
  • dry eyes
  • cataracts
  • epistaxis
  • oropharyngeal pain
  • arthralgia
  • osteoporosis
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • ureterolithiasis
  • hematuria
  • renal mass
  • urinary retention
  • vulvar pruritus
  • genital pruritus
  • hypotension
  • flushing
  • hepatic steatosis
  • ear pain
  • orthostatic dizziness
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • headache
  • dizziness
  • chest discomfort
  • asthenia
  • weight loss
  • benign prostatic hyperplasia
  • dyslipidemia
  • obesity
  • fatigue
  • hyponatremia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • ring dermatitis
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • limb pain
  • musculoskeletal chest pain
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival injection
  • pathologic myopia
  • retinal crystals
  • retinal vein occlusion
  • lattice retinal detachment
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin lacerations
  • rib fractures
  • iliotibial band syndrome
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular disorders
  • peripheral arterial occlusive disease
  • unstable angina
  • sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The proper storage temperature is room temperature between 1°C and 30°C. Avoid storage in excessively hot or cold places.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.